Omega Healthcare Investors, Inc. (NYSE:OHI) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Omega Healthcare Investors, Inc. has received a consensus rating of "Moderate Buy" from eleven brokerages, with six providing buy ratings and five suggesting a hold.
• The company's stock has seen a recent price target increase, now averaging $44.50 among analysts, with notable upgrades from firms such as Scotiabank and Cantor Fitzgerald.
• For its latest quarter, Omega Healthcare reported $0.77 earnings per share, exceeding expectations, and set FY 2025 guidance in the range of 3.040-3.070 EPS.

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven brokerages that are presently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $44.50.

OHI has been the subject of a number of recent research reports. Scotiabank boosted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a report on Thursday, August 28th. Cantor Fitzgerald initiated coverage on shares of Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 price objective for the company. Raymond James Financial reissued an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research note on Wednesday, September 3rd. Finally, Mizuho boosted their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday, September 11th.

Omega Healthcare Investors Stock Performance

Shares of OHI opened at $40.48 on Friday. Omega Healthcare Investors has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a market cap of $11.94 billion, a PE ratio of 24.99, a price-to-earnings-growth ratio of 1.90 and a beta of 0.70. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a 50-day moving average price of $41.59 and a 200-day moving average price of $39.00.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same period in the previous year, the firm posted $0.71 EPS. The firm's revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, equities analysts forecast that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.50% of the company's stock.

Institutional Investors Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd bought a new stake in Omega Healthcare Investors during the 2nd quarter valued at $26,000. Salem Investment Counselors Inc. bought a new position in shares of Omega Healthcare Investors during the third quarter valued at about $39,000. Smartleaf Asset Management LLC raised its stake in shares of Omega Healthcare Investors by 40.9% during the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after acquiring an additional 268 shares during the last quarter. CENTRAL TRUST Co raised its stake in shares of Omega Healthcare Investors by 1,654.4% during the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust's stock valued at $37,000 after acquiring an additional 943 shares during the last quarter. Finally, True Wealth Design LLC raised its stake in shares of Omega Healthcare Investors by 273.5% during the third quarter. True Wealth Design LLC now owns 1,113 shares of the real estate investment trust's stock valued at $47,000 after acquiring an additional 815 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.